Health
Singapore group will develop 'most promising' Ebola vaccine

What the report says
The Singapore-based Hilleman Laboratories announced it would advance the rVSV Bundibugyo jab so it can be tested on humans during clinical trials.
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

HTTC Crowns Uganda’s Finest Young Hospitality TalentNile Post
Pets improve kids’ mental health — except one, which makes things worse - New York PostNew York Post